MedTrace Logo

Indomethacin and Mechanisms Underlying Risk of Falling

NCT00462111 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2012-02-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether indometacin has an effect on reaction time, postural stability, and the avoidance of obstacles.

Conditions

  • Healthy

Interventions

DRUG

Indometacin

Sponsors & Collaborators

  • Sint Maartenskliniek

    lead OTHER

Principal Investigators

  • Jacques van Limbeek, MD · Sint Maartenskliniek

  • Jaak Duysens, Prof · St Maartenskliniek and University Medical Centre St. Radboud, Nijmegen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00462111 on ClinicalTrials.gov